Robert A. Somer
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Cancer Risks and Factors
- CAR-T cell therapy research
- Cancer Treatment and Pharmacology
-
- Oral health in cancer treatment
Papers in
- Oncology 19
- Cancer Treatment and Pharmacology 5
- HER2/EGFR in Cancer Research 4
-
- Lung Cancer Treatments and Mutations 5
- Prostate Cancer Treatment and Research 4
- Brain Metastases and Treatment 4
- Co-authors
- Elyce Cardonick (2 shared papers)Kevin M. Chin (1 shared paper)Guy Jérusalem (1 shared paper)Luc Dirix (1 shared paper)Andres Forero‐Torres (1 shared paper)Borys Hrinczenko (1 shared paper)Martin Šmakal (1 shared paper)Petros Nikolinakos (1 shared paper)
- Journals
- Journal of Clinical Oncology (9 papers)Annals of Oncology (3 papers)Clinical Genitourinary Cancer (2 papers)Cancer Research (2 papers)Clinical Lung Cancer (2 papers)
- Partner nations
- United StatesGermanySpain
In The Last Decade
Robert A. Somer
34 papers receiving 1.3k citations
Robert A. Somer's Hit Papers
Peers
Comparison fields: 5 of 68
- Oncology 841
- Pulmonary and Respiratory Medicine 346
- Immunology 230
- Cancer Research 157
- Otorhinolaryngology 40
Countries citing papers authored by Robert A. Somer
This map shows the geographic impact of Robert A. Somer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Somer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Somer more than expected).
Fields of papers citing papers by Robert A. Somer
This network shows the impact of papers produced by Robert A. Somer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Somer. The network helps show where Robert A. Somer may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert A. Somer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study Hit paper breakdown → | 2017 | 593 |
| 2 | 2003 | 118 | |
| 3 | 2004 | 95 | |
| 4 | 2012 | 87 | |
| 5 | 2012 | 57 | |
| 6 | 2012 | 49 | |
| 7 | 2017 | 34 | |
| 8 | 2012 | 33 | |
| 9 | 2002 | 32 | |
| 10 | 2017 | 24 | |
| 11 | 2008 | 23 | |
| 12 | 2012 | 19 | |
| 13 | 2011 | 17 | |
| 14 | 2019 | 16 | |
| 15 | 2013 | 15 | |
| 16 | 2019 | 11 | |
| 17 | 2016 | 9 | |
| 18 | 2023 | 7 | |
| 19 | 2007 | 7 | |
| 20 | 2009 | 7 |
About Robert A. Somer
Robert A. Somer is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Surgery, having authored 36 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), Lung Cancer Treatments and Mutations (5 papers), HER2/EGFR in Cancer Research (4 papers), Bladder and Urothelial Cancer Treatments (4 papers), Prostate Cancer Treatment and Research (4 papers), Brain Metastases and Treatment (4 papers), Cancer Genomics and Diagnostics (3 papers) and Cancer, Lipids, and Metabolism (3 papers). The work is most often cited by research in Oncology (841 citations), Pulmonary and Respiratory Medicine (346 citations), Immunology (230 citations), Cancer Research (157 citations) and Otorhinolaryngology (40 citations). Robert A. Somer has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include Elyce Cardonick, Kevin M. Chin, Guy Jérusalem, Luc Dirix, Andres Forero‐Torres, Borys Hrinczenko, Martin Šmakal, Petros Nikolinakos, Anja von Heydebreck and Marc E. Lippman. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Genitourinary Cancer, Cancer Research and Clinical Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.